DrugPatentWatch Database Preview
Drugs in Development Information for Batefenterol
What is the drug development status for Batefenterol?
Batefenterol is an investigational drug.
There have been 4 clinical trials for Batefenterol.
The most recent clinical trial was a Phase 2 trial, which was initiated on December 1st 2015.
The most common disease conditions in clinical trials are Pulmonary Disease, Chronic Obstructive, Lung Diseases, and Chronic Disease. The leading clinical trial sponsors are GlaxoSmithKline, Hammersmith Medicines Research, and [disabled in preview].
There are nine US patents protecting this investigational drug and one hundred and fifty-nine international patents.
Summary for Batefenterol
| US Patents | 9 |
| International Patents | 159 |
| US Patent Applications | 14 |
| WIPO Patent Applications | 9 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 2 (2015-12-01) |
| Vendors | 22 |
Recent Clinical Trials for Batefenterol
| Title | Sponsor | Phase |
|---|---|---|
| A Phase 1 (Ph1), Single Dose (SD), GSK961081 Absorption, Distribution, Metabolism, and Excretion (ADME) Study in Healthy Subjects | Hammersmith Medicines Research | Phase 1 |
| A Phase 1 (Ph1), Single Dose (SD), GSK961081 Absorption, Distribution, Metabolism, and Excretion (ADME) Study in Healthy Subjects | GlaxoSmithKline | Phase 1 |
| GSK961081 Alone and With Fluticasone Furoate (FF), Phase 1 (Ph1), Single Dose Regimen (SD), Repeat Dose Regimen (RD), Pharmacokinetic (PK) Study in Healthy Volunteer (HV) | Hammersmith Medicines Research | Phase 1 |
Clinical Trial Summary for Batefenterol
Top disease conditions for Batefenterol
Top clinical trial sponsors for Batefenterol
US Patents for Batefenterol
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Batefenterol | Start Trial | Biphenyl derivatives | Theravance, Inc. (South San Francisco, CA) | Start Trial |
| Batefenterol | Start Trial | Crystalline form of a biphenyl compound | Theravance, Inc. (South San Francisco, CA) | Start Trial |
| Batefenterol | Start Trial | Biphenyl derivatives | Theravance, Inc. (South San Francisco, CA) | Start Trial |
| Batefenterol | Start Trial | Compound | Glaxo Group Limited (Greenford, Middlesex, GB) | Start Trial |
| Batefenterol | Start Trial | Crystalline form of a biphenyl compound | Theravance, Inc. (South San Francisco, CA) | Start Trial |
| Batefenterol | Start Trial | Crystalline form of a biphenyl compound | Theravance, Inc. (South San Francisco, CA) | Start Trial |
| Batefenterol | Start Trial | Process for the preparation of a biphenyl-2-yl carbamic acid ester | Glaxo Group Limited (Greenford, Middlesex, GB) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Batefenterol
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Batefenterol | Argentina | 043176 | 2023-02-14 | Start Trial |
| Batefenterol | Argentina | 098785 | 2023-02-14 | Start Trial |
| Batefenterol | Austria | 482934 | 2023-02-14 | Start Trial |
| Batefenterol | Australia | 2004213411 | 2023-02-14 | Start Trial |
| Batefenterol | Australia | 2010219338 | 2023-02-14 | Start Trial |
| Batefenterol | Brazil | PI0407508 | 2023-02-14 | Start Trial |
| Batefenterol | Canada | 2515777 | 2023-02-14 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
